These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
582 related items for PubMed ID: 16326053
1. A pilot study of freeze drying of poly(epsilon-caprolactone) nanocapsules stabilized by poly(vinyl alcohol): formulation and process optimization. Abdelwahed W, Degobert G, Fessi H. Int J Pharm; 2006 Feb 17; 309(1-2):178-88. PubMed ID: 16326053 [Abstract] [Full Text] [Related]
2. Freeze-drying of nanocapsules: impact of annealing on the drying process. Abdelwahed W, Degobert G, Fessi H. Int J Pharm; 2006 Oct 31; 324(1):74-82. PubMed ID: 16904277 [Abstract] [Full Text] [Related]
3. Investigation of nanocapsules stabilization by amorphous excipients during freeze-drying and storage. Abdelwahed W, Degobert G, Fessi H. Eur J Pharm Biopharm; 2006 Jun 31; 63(2):87-94. PubMed ID: 16621490 [Abstract] [Full Text] [Related]
4. Spray-freeze-drying production of thermally sensitive polymeric nanoparticle aggregates for inhaled drug delivery: effect of freeze-drying adjuvants. Cheow WS, Ng ML, Kho K, Hadinoto K. Int J Pharm; 2011 Feb 14; 404(1-2):289-300. PubMed ID: 21093560 [Abstract] [Full Text] [Related]
5. Freeze drying of human serum albumin (HSA) nanoparticles with different excipients. Anhorn MG, Mahler HC, Langer K. Int J Pharm; 2008 Nov 03; 363(1-2):162-9. PubMed ID: 18672043 [Abstract] [Full Text] [Related]
6. Spray-dried microparticles containing polymeric nanocapsules: formulation aspects, liquid phase interactions and particles characteristics. Tewa-Tagne P, Briançon S, Fessi H. Int J Pharm; 2006 Nov 15; 325(1-2):63-74. PubMed ID: 16872767 [Abstract] [Full Text] [Related]
7. Preparation of redispersible dry nanocapsules by means of spray-drying: development and characterisation. Tewa-Tagne P, Briançon S, Fessi H. Eur J Pharm Sci; 2007 Feb 15; 30(2):124-35. PubMed ID: 17150339 [Abstract] [Full Text] [Related]
8. On the use of tert-butanol/water cosolvent systems in production and freeze-drying of poly-ε-caprolactone nanoparticles. Zelenková T, Barresi AA, Fissore D. J Pharm Sci; 2015 Jan 15; 104(1):178-90. PubMed ID: 25421731 [Abstract] [Full Text] [Related]
9. Physical characterisation of formulations for the development of two stable freeze-dried proteins during both dried and liquid storage. Passot S, Fonseca F, Alarcon-Lorca M, Rolland D, Marin M. Eur J Pharm Biopharm; 2005 Aug 15; 60(3):335-48. PubMed ID: 15894475 [Abstract] [Full Text] [Related]
10. [Freeze-drying of oleanolic acid-loaded nanosuspensions]. Zhao XL, Chen HB, Chen YJ, Yang XL. Zhongguo Zhong Yao Za Zhi; 2007 Sep 15; 32(18):1874-6. PubMed ID: 18051893 [Abstract] [Full Text] [Related]
11. Distinct effects of sucrose and trehalose on protein stability during supercritical fluid drying and freeze-drying. Jovanović N, Bouchard A, Hofland GW, Witkamp GJ, Crommelin DJ, Jiskoot W. Eur J Pharm Sci; 2006 Mar 15; 27(4):336-45. PubMed ID: 16338123 [Abstract] [Full Text] [Related]
12. Freeze drying of nanosuspensions, 2: the role of the critical formulation temperature on stability of drug nanosuspensions and its practical implication on process design. Beirowski J, Inghelbrecht S, Arien A, Gieseler H. J Pharm Sci; 2011 Oct 15; 100(10):4471-81. PubMed ID: 21607957 [Abstract] [Full Text] [Related]
13. Stability of cyclosporine-loaded poly-sigma-caprolactone nanoparticles. Molpeceres J, Aberturas MR, Chacón M, Berges L, Guzmán M. J Microencapsul; 1997 Oct 15; 14(6):777-87. PubMed ID: 9394259 [Abstract] [Full Text] [Related]
14. Rapid determination of dry layer mass transfer resistance for various pharmaceutical formulations during primary drying using product temperature profiles. Kuu WY, Hardwick LM, Akers MJ. Int J Pharm; 2006 Apr 26; 313(1-2):99-113. PubMed ID: 16513303 [Abstract] [Full Text] [Related]
15. Freeze-drying of squalenoylated nucleoside analogue nanoparticles. Bildstein L, Hillaireau H, Desmaële D, Lepêtre-Mouelhi S, Dubernet C, Couvreur P. Int J Pharm; 2009 Nov 03; 381(2):140-5. PubMed ID: 19782881 [Abstract] [Full Text] [Related]
16. Stability study of drug-loaded proteinoid microsphere formulations during freeze-drying. Ma X, Santiago N, Chen YS, Chaudhary K, Milstein SJ, Baughman RA. J Drug Target; 1994 Nov 03; 2(1):9-21. PubMed ID: 8069587 [Abstract] [Full Text] [Related]
17. Influence of the stabilizer coating layer on the purification and freeze-drying of poly(D,L-lactic acid) nanoparticles prepared by an emulsion-diffusion technique. Quintanar-Guerrero D, Ganem-Quintanar A, Allémann E, Fessi H, Doelker E. J Microencapsul; 1998 Nov 03; 15(1):107-19. PubMed ID: 9463812 [Abstract] [Full Text] [Related]
18. Freeze drying optimization of polymeric nanoparticles for ocular flurbiprofen delivery: effect of protectant agents and critical process parameters on long-term stability. Ramos Yacasi GR, Calpena Campmany AC, Egea Gras MA, Espina García M, García López ML. Drug Dev Ind Pharm; 2017 Apr 03; 43(4):637-651. PubMed ID: 28044462 [Abstract] [Full Text] [Related]
19. Impact of formulation on the quality and stability of freeze-dried nanoparticles. Luo WC, O'Reilly Beringhs A, Kim R, Zhang W, Patel SM, Bogner RH, Lu X. Eur J Pharm Biopharm; 2021 Dec 03; 169():256-267. PubMed ID: 34732383 [Abstract] [Full Text] [Related]
20. Stability study perspective of the effect of freeze-drying using cryoprotectants on the structure of insulin loaded into PLGA nanoparticles. Fonte P, Soares S, Sousa F, Costa A, Seabra V, Reis S, Sarmento B. Biomacromolecules; 2014 Oct 13; 15(10):3753-65. PubMed ID: 25180545 [Abstract] [Full Text] [Related] Page: [Next] [New Search]